Ralf Kittler to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Ralf Kittler has written about Drug Resistance, Neoplasm.
Connection Strength
1.354
-
Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations. Cancer Res. 2021 09 15; 81(18):4685-4695.
Score: 0.589
-
Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer. Cancer Lett. 2018 12 01; 438:86-96.
Score: 0.483
-
Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer. Clin Cancer Res. 2021 08 01; 27(15):4379-4396.
Score: 0.145
-
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors. Cell Rep. 2017 05 23; 19(8):1669-1684.
Score: 0.110
-
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov. 2017 08; 7(8):832-851.
Score: 0.027